Related references
Note: Only part of the references are listed.IGF2/H19 hypomethylation in a patient with very low birthweight, preocious pubarche and insulin resistance
Rinki Murphy et al.
BMC MEDICAL GENETICS (2012)
Effects of Cord Serum Insulin, IGF-II, IGFBP-2, IL-6 and Cortisol Concentrations on Human Birth Weight and Length: Pilot Study
Arianna Smerieri et al.
PLOS ONE (2011)
Coordinated postnatal down-regulation of multiple growth-promoting genes: evidence for a genetic program limiting organ growth
Julian C. Lui et al.
FASEB JOURNAL (2010)
E2f3a and E2f3b Contribute to the Control of Cell Proliferation and Mouse Development
Jean-Leon Chong et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
p53 and E2f: partners in life and death
Shirley Polager et al.
NATURE REVIEWS CANCER (2009)
An imprinted gene network that controls mammalian somatic growth is down-regulated during postnatal growth deceleration in multiple organs
Julian C. Lui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
The E2F3-Oncomir-1 axis is activated in Wilms' tumor
Eric J. Kort et al.
CANCER RESEARCH (2008)
E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites
Alina Rabinovich et al.
GENOME RESEARCH (2008)
Severe Intrauterine Growth Retardation and Atypical Diabetes Associated with a Translocation Breakpoint Disrupting Regulation of the Insulin-Like Growth Factor 2 Gene
R. Murphy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mouse development with a single E2F activator
Shih-Yin Tsai et al.
NATURE (2008)
Specific in vivo roles for E2Fs in differentiation and development
Kelly A. McClellan et al.
CELL CYCLE (2007)
Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors
Hans T. Bjornsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells
A. Y. Olsson et al.
ONCOGENE (2007)
E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer
M. Oeggerli et al.
ONCOGENE (2006)
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human
D Monk et al.
HUMAN MOLECULAR GENETICS (2006)
Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome
C Gicquel et al.
NATURE GENETICS (2005)
Mulan: Multiple-sequence local alignment and visualization for studying function and evolution
I Ovcharenko et al.
GENOME RESEARCH (2005)
Amplification and overexpression of E2F3 in human bladder cancer
A Feber et al.
ONCOGENE (2004)
Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome
CS Foster et al.
ONCOGENE (2004)
E2F target genes: unraveling the biology
AP Bracken et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
M Oeggerli et al.
ONCOGENE (2004)
Placental-specific IGF-II is a major modulator of placental and fetal growth
M Constância et al.
NATURE (2002)
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma
H Hahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins
G Leone et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon
R Mineo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
